GenomeWebTempus Ramps Up AI-Driven Precision Oncology, Eyes Other MarketsDec 03, 2018CardiologyClinical TrialsOncologyHereditaryNeuro/PsychProduct LaunchMedia CoverageRelated contentA Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 YearsTempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer SymposiumTempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test